Compare AEXA & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AEXA | SOPH |
|---|---|---|
| Founded | 2025 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 564.3M | 462.3M |
| IPO Year | 2025 | 2021 |
| Metric | AEXA | SOPH |
|---|---|---|
| Price | $11.20 | $8.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 63.9K | ★ 631.3K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.49 | $3.37 |
| 52 Week High | $11.99 | $8.98 |
| Indicator | AEXA | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 40.70 | 55.90 |
| Support Level | $11.02 | $4.63 |
| Resistance Level | $11.49 | $8.98 |
| Average True Range (ATR) | 0.22 | 0.40 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 27.14 | 60.68 |
American Exceptionalism Acquisition Corp A is a blank check company.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.